Bio-Thera Solutions, Ltd. (SHA:688177)
16.24
-0.53 (-3.16%)
At close: Sep 11, 2026
Bio-Thera Solutions Revenue
Bio-Thera Solutions had revenue of 266.96M CNY in the quarter ending June 30, 2026, with 13.44% growth. This brings the company's revenue in the last twelve months to 1.01B, up 29.27% year-over-year. In the year 2025, Bio-Thera Solutions had annual revenue of 935.22M with 25.84% growth.
Revenue (ttm)
1.01B
Revenue Growth
+29.27%
P/S Ratio
6.65
Revenue / Employee
709.59K
Employees
1,426
Market Cap
6.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 935.22M | 192.05M | 25.84% |
| Dec 31, 2024 | 743.17M | 38.37M | 5.44% |
| Dec 31, 2023 | 704.79M | 249.66M | 54.86% |
| Dec 31, 2022 | 455.13M | -381.45M | -45.60% |
| Dec 31, 2021 | 836.58M | 653.72M | 357.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.93B |
| Aurisco Pharmaceutical | 1.70B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.69B |
| Chengdu Kanghua Biological Products | 1.22B |
| Wuhan Keqian Biology Co.,Ltd | 836.28M |
| Zhejiang Ausun Pharmaceutical | 778.50M |
| Daan Gene | 746.91M |
| Jiangsu Aidea Pharmaceutical Group | 722.54M |